Steven Applebaum

475 total citations
9 papers, 347 citations indexed

About

Steven Applebaum is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Developmental Biology. According to data from OpenAlex, Steven Applebaum has authored 9 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Developmental Biology. Recurrent topics in Steven Applebaum's work include Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Steven Applebaum is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Steven Applebaum collaborates with scholars based in United States, Japan and Italy. Steven Applebaum's co-authors include R. Gregg Settle, Hiroyuki Zusho, Richard L. Doty, John A. Glaspy, SA Hurvitz, DJ Slamon, RS Finn, Rachel Courtney, Sophia Randolph and Barbara T. Shapiro and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Neuropsychologia.

In The Last Decade

Steven Applebaum

8 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven Applebaum United States	6	222	148	138	67	45	9	347
Paul Scholz Germany	11	247 1.1×	91 0.6×	194 1.4×	7 0.1×	10 0.2×	14	338
Mark Wake Canada	10	258 1.2×	11 0.1×	12 0.1×	36 0.5×	27 0.6×	13	383
Louise Robson United Kingdom	13	27 0.1×	11 0.1×	26 0.2×	7 0.1×	48 1.1×	29	441
Haiyang Lang China	11	13 0.1×	32 0.2×	9 0.1×	25 0.4×	13 0.3×	18	336
Sarim Mohammad United Kingdom	5	26 0.1×	37 0.3×	37 0.3×	26 0.4×	5 0.1×	9	460
Ga-Young Lee South Korea	8	6 0.0×	28 0.2×	22 0.2×	24 0.4×	4 0.1×	17	389
Marta Gil Spain	8	18 0.1×	3 0.0×	28 0.2×	105 1.6×	20 0.4×	22	348
Seul-Ki Choi South Korea	9	7 0.0×	17 0.1×	14 0.1×	17 0.3×	30 0.7×	15	272
Maria G. Macedo Netherlands	7	34 0.2×	21 0.1×	71 0.5×	11 0.2×	4 0.1×	8	346

Countries citing papers authored by Steven Applebaum

Since Specialization

Citations

This map shows the geographic impact of Steven Applebaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Applebaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Applebaum more than expected).

Fields of papers citing papers by Steven Applebaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Applebaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Applebaum. The network helps show where Steven Applebaum may publish in the future.

Co-authorship network of co-authors of Steven Applebaum

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Applebaum. A scholar is included among the top collaborators of Steven Applebaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Applebaum. Steven Applebaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hurvitz, Sara A., David W. Chan, Thomas J. Lomis, et al.. (2022). TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.. Journal of Clinical Oncology. 40(16_suppl). TPS623–TPS623. 21 indexed citations

Hurvitz, Sara A., Heather Allen, Rebecca Moroose, et al.. (2010). A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01). Clinical Breast Cancer. 10(4). 307–312. 7 indexed citations

Slamon, DJ, SA Hurvitz, Steven Applebaum, et al.. (2010). Phase I study of PD 0332991, cyclin-D kinase (CDK) 4/6 inhibitor in combination with letrozole for first-line treatment of patients with ER-positive, HER2-negative breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 3060–3060. 26 indexed citations

Finn, RS, SA Hurvitz, Mary Ann Allison, et al.. (2009). Phase I Study of PD 0332991, a Novel, Oral, Cyclin-D Kinase (CDK) 4/6 Inhibitor in Combination with Letrozole, for First-Line Treatment of Metastatic Post-Menopausal, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer.. Cancer Research. 69(24_Supplement). 5069–5069. 13 indexed citations

Hurvitz, Sara A., Heather Allen, R Moroose, et al.. (2008). Final results of a phase II study of bevacizumab plus docetaxel for the first-line treatment of metastatic breast cancer (TORI-B01). European Journal of Cancer Supplements. 6(7). 217–217. 1 indexed citations

Applebaum, Steven, et al.. (2003). Retention strategies in aerospace turnover: a case study. Career Development International. 8(6). 270–282. 13 indexed citations

Doty, Richard L., Steven Applebaum, Hiroyuki Zusho, & R. Gregg Settle. (1985). Sex differences in odor identification ability: A cross-cultural analysis. Neuropsychologia. 23(5). 667–672. 260 indexed citations

Gaioni, Stephen J., et al.. (1983). The response of young peking duklings to sibling distress calls. Developmental Psychobiology. 16(5). 423–437. 5 indexed citations

Applebaum, Steven. (1975). Geology of the Palo Verde Ranch Area, Owl Head Mining District, Pinal County, Arizona. UA Campus Repository (The University of Arizona). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact